Isoflurane attenuates myoglobin release during ischemic and/or reperfusion periods

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 5, 2008, Pages 650-657

  Kitagawa, H ^a   Yamazaki, T ^b   Akiyama, T ^b   Nosaka, S ^a   Mori, H ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Heart; Ischemia; Protection

Indexed keywords

ISOFLURANE; MYOGLOBIN; SODIUM CYANIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSATE; DIALYSATE LEVEL; DIALYSIS; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; RABBIT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANESTHETICS, INHALATION; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HEART RATE; ISOFLURANE; MALE; MICRODIALYSIS; MYOCARDIUM; MYOGLOBIN; RABBITS; REPERFUSION INJURY; SODIUM CYANIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 42249094015     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01601.x     Document Type: Article

References (25)

1. Kersten JR, Schmeling TJ, Pagel PS et al. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997 87 : 361 70.
2. Sommerschild HT, Kirkebøen KA. Preconditoning-endgenous defense mechanisms of the heart. Acta Anaesthesiol Scand 2002 46 : 123 37.
3. Piriou V, Chiari P, Lhuillier F et al. Pharmacological preconditioning: comparison of desflurane, Sevoflurane, isoflurane and halothane in rabbit myocardium. Br J Anaeth 2002 89 : 486 91.
4. Riess ML, Kevin LG, McCormick J et al. Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts. Anesth Analg 2005 100 : 46 53.
5. Riess ML, Kevin LG, Camara AK et al. Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. Anesthesiology 2004 100 : 569 74.
6. Raphael J, Abedat S, Rivo J et al. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 2006 318 : 186 94.
7. Miura T. Does reperfusion induce myocardial necrosis? Circulation 1990 82 : 1070 2.
8. Kitagawa H, Yamazaki T, Akiyama T et al. Microdialysis separately monitors myocardial interstitial myoglobin during ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2005 289 : H924 30.
9. Kitagawa H, Akiyama T, Yamazaki T. Myocardial interstitial noradrenalin monitoring during occlusion of inferior vena cava in cats. Acta Physiol Scand 1998 163 : 173 9.
10. Yamazaki T, Akiyama T, Kitagawa H et al. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities. Am J Physiol 1997 272 : H1182 7.
11. Cason BA, Gamperl AK, Slocum RE et al. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997 87 : 1182 90.
12. Beuerle JR, Azzazy HM, Styba G et al. Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patients. Clin Chim Acta 2000 294 : 115 28.
13. Vuotikka P, Ylitalo K, Vuori J et al. Serum myoglobin/carbonic anhydrase III ratio in the diagnosis of perioperative myocardial infarction during coronary bypass surgery. Scand Cardiovasc J 2003 37 : 23 9.
14. Férez Santander SM, Márquez MF, Peña Duque MA et al. Myocardial reperfusion injury. Rev Esp Cardiol 2004 57 (Suppl. 1) : 9 21.
15. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anesth 2002 49 : 777 91.
16. Tanaka K, Ludwig LM, Kersten JR et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004 100 : 707 21.
17. De Hert SG, Turani F, Mathur S et al. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005 100 : 1584 93.
18. Feng J, Fischer G, Lucchinetti E et al. Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase B/Akt signaling. Anesthesiology 2006 104 : 1004 14.
19. Ismaeil MS, Tkachenko I, Gamperl AK et al. Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. Anesthesiology 1999 90 : 812 21.
20. Müllenheim J, Ebel D, Frässdorf J et al. Isoflurane preconditioning myocardium against infarction via release of free radicals. Anesthesiology 2002 96 : 934 40.
21. Toller WG, Kersten JR, Gross ER et al. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 2000 92 : 1400 7.
22. Raphael J, Rivo J, Gozal Y. Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signaling. Br J Anaesth 2005 95 : 756 63.
23. Marinovic J, Bosnjak ZJ, Stadnicka A. Preconditioning by isoflurane induces lasting sensitization of the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel by a protein kinase C-delta-mediated mechanism. Anesthesiology 2005 103 : 540 7.
24. Ludwig LM, Weihrauch D, Kersten JR et al. Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 2004 100 : 532 9.
25. Cope DK, Impastato WK, Cohen MV et al. Volatile anesthetic protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997 86 : 699 709.